Abstract
in Cohort 2 (mean age 65± 10 yrs, median follow-up 23 months. MACE and independent outcomes were not significantly different during follow up with low TVR and ST reported in both cohorts (Table). Cohort 1(≤2.75mm EES) n= 91 Cohort 2(≥3.00mm EES) n= 118 P Value Age 61+ 12 yrs 65± 10 yrs Male 59% 70% 0.11 All-cause mortality 5 (6%) 6 (5%) 1.00 MI 2 (2%) 1 (1%) 0.58 TVR 3 (3%) 3 (3%) 1.00 ST 1 (1%) 0 (0%) 0.44 MACE 11 (12%) 10 (9%) 0.34 Conclusion:Everolimus-eluting stent use in the realworld is associated with good clinical outcomes and low adverse event rates in both small and large coronary vessels. Conflicts of interests:Nil. doi:10.1016/j.hlc.2011.03.055 Post-Transcatheter Aortic Valve Implantation (TAVI) Related New Onset Left-Bundle Branch Block and Its Short-Term Effect on Left Ventricular Ejection Fraction
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
